At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.（Learn more at https://www.jnj.com/.）
Johnson & Johnson Pharmaceutical LTD. (hereinafter referred to as "JJP") is a wholly-owned subsidiary of Johnson & Johnson (China) Investment Ltd. registered in Beijing Tianzhu Free Trade Zone on June 1, 2022, JJP's establishment is part of NEW Johnson & Johnson's global strategy and a reflection of Johnson & Johnson's global emphasis on the Chinese market and its commitment to Chinese patients.